A nested case-control study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3

European Journal of Cancer

Volumn 43, Issue 10, 2007, Pages 1611-1616

  Pham, Truong Minh ^a,b,f   Fujino, Yoshihisa ^a,f   Kikuchi, Shogo ^c,f   Tamakoshi, Akiko ^d,f   Yatsuya, Hiroshi ^d,f   Matsuda, Shinya ^a,f   Yoshimura, Takesumi ^e,f  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b THAI NGUYEN UNIVERSITY   (Viet Nam)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^f NONE

Author keywords

IGF; Insulin like growth factor; JACC Study; Nested case control study; Stomach cancer

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; JAPAN; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS;

EID: 34250190242     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.04.014     Document Type: Article

References (23)

1. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 (1999) 827-841
2. Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labor and Welfare. Vital statistics of Japan. Tokyo: Health and Welfare Statistics Association; 2004.
3. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16 (1995) 3-34
4. Khandwala H.M., McCutcheon I.E., Flyvbjerg A., and Friend K.E. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21 (2000) 215-244
5. Renehan A.G., Zwahlen M., Minder C., O'Dwyer S.T., Shalet S.M., and Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
6. Yu H., and Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92 (2000) 1472-1489
7. Yu H., Spitz M.R., Mistry J., Gu J., Hong W.K., and Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91 (1999) 151-156
8. Sugumar A., Liu Y.C., Xia Q., Koh Y.S., and Matsuo K. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer 111 (2004) 293-297
9. Nomura A.M., Stemmermann G.N., Lee J., and Pollak M.N. Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American men. Am J Epidemiol 158 (2003) 424-431
10. Lin Y., Tamakoshi A., Kikuchi S., et al. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer 110 (2004) 584-588
11. Lee D.Y., Yang D.H., Kang C.W., et al. Serum insulin-like growth factors (IGFs) and IGF binding protein (IGFBP)-3 in patients with gastric cancer: IGFBP-3 protease activity induced by surgery. J Korean Med Sci 12 (1997) 32-39
12. Yatsuya H., Toyoshima H., Tamakoshi K., et al. Serum levels of insulin-like growth factor I, II, and binding protein 3, transforming growth factor beta-1, soluble fas ligand and superoxide dismutase activity in stomach cancer cases and their controls in the JACC Study. J Epidemiol 15 Suppl 2 (2005) S120-S125
13. Tamakoshi A., Yoshimura T., Inaba Y., et al. Profile of the JACC study. J Epidemiol 15 Suppl 1 (2005) S4-S8
14. Ohno Y., and Tamakoshi A. Japan collaborative cohort study for evaluation of cancer risk sponsored by monbusho (JACC study). J Epidemiol 11 (2001) 144-150
15. StataCorp. Stata Statistical Sofware: Release 9. College Station, Texas: StataCorp LP; 2005.
16. Oh Y., Muller H.L., Neely E.K., Lamson G., and Rosenfeld R.G. New concepts in insulin-like growth factor receptor physiology. Growth Regul 3 (1993) 113-123
17. Sara V.R., and Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev 70 (1990) 591-614
18. LeRoith D., Baserga R., Helman L., and Roberts C.T.J. Insulin-like growth factors and cancer. Ann Intern Med 122 (1995) 54-59
19. Pietrzkowski Z., Mulholland G., Gomella L., Jameson B.A., Wernicke D., and Baserga R. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res 53 (1993) 1102-1106
20. Frostad S., and Bruserud O. In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts. Eur J Haematol 62 (1999) 191-198
21. Singh P., Dai B., Yallampalli U., Lu X., and Schroy P.C. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II. Endocrinology 137 (1996) 1764-1774
22. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23 (2002) 824-854
23. Franciosi C.M., Piacentini M.G., Conti M., et al. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study. Hepatogastroenterology 50 (2003) 297-300